Preliminary reports indicate conolidine could inhibit specific ion channels, decreasing neuronal excitability and restricting soreness indicators. This mechanism is particularly relevant in neuropathic discomfort, where abnormal signaling results in persistent irritation. Additionally, conolidine seems to influence G protein-coupled receptor (GPCR) pathways integral to soreness notion... https://hallajq469oib4.wikikarts.com/user